Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Predicting cancer immunotherapy response from gut microbiomes using machine learning models
Hai Liang, Jay‐Hyun Jo, Zhiwei Zhang, et al.
Oncotarget (2022) Vol. 13, Iss. 1, pp. 876-889
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

An integrated tumor, immune and microbiome atlas of colon cancer
Jessica Roelands, Peter J.K. Kuppen, Eiman I. Ahmed, et al.
Nature Medicine (2023) Vol. 29, Iss. 5, pp. 1273-1286
Open Access | Times Cited: 101
Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review
Arsela Prelaj, Vanja Mišković, Michele Zanitti, et al.
Annals of Oncology (2023) Vol. 35, Iss. 1, pp. 29-65
Open Access | Times Cited: 100
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
Ashley M. Holder, Aikaterini Dedeilia, Kailan Sierra-Davidson, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 7, pp. 498-512
Closed Access | Times Cited: 60
Multi-kingdom gut microbiota analyses define bacterial-fungal interplay and microbial markers of pan-cancer immunotherapy across cohorts
Xiaowen Huang, Muni Hu, Tiantian Sun, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 11, pp. 1930-1943.e4
Open Access | Times Cited: 40
Microbiome bacterial influencers of host immunity and response to immunotherapy
Yeganeh Yousefi, Kelly J. Baines, Saman Maleki Vareki
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101487-101487
Open Access | Times Cited: 14
Deciphering the gut microbiome: The revolution of artificial intelligence in microbiota analysis and intervention
Mohammad Abavisani, Alireza Khoshrou, Sobhan Karbas Foroushan, et al.
Current Research in Biotechnology (2024) Vol. 7, pp. 100211-100211
Open Access | Times Cited: 13
The role of microbiomes in gastrointestinal cancers: new insights
Aref Yarahmadi, Hamed Afkhami
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 12
GSR-DB: a manually curated and optimized taxonomical database for 16S rRNA amplicon analysis
Leidy-Alejandra G Molano, Sara Vega-Abellaneda, Chaysavanh Manichanh
mSystems (2024) Vol. 9, Iss. 2
Open Access | Times Cited: 11
A review of machine learning methods for cancer characterization from microbiome data
Marco Teixeira, Francisco Silva, Rui M. Ferreira, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 9
The Role of the Gut Microbiome in Cancer Immunotherapy: Current Knowledge and Future Directions
Despoina Eugenia Kiousi, Antonia Z. Kouroutzidou, Konstantinos Neanidis, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2101-2101
Open Access | Times Cited: 21
Methodology for biomarker discovery with reproducibility in microbiome data using machine learning
David Rojas-Velázquez, Sarah Kidwai, Aletta D. Kraneveld, et al.
BMC Bioinformatics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 6
Reproducible gut microbial signatures in bipolar and schizophrenia spectrum disorders: A metagenome-wide study
Magdalini Ioannou, Jenny Borkent, Sergio Andreu‐Sánchez, et al.
Brain Behavior and Immunity (2024) Vol. 121, pp. 165-175
Open Access | Times Cited: 6
Gut Microbiota Are a Novel Source of Biomarkers for Immunotherapy in Non-Small-Cell Lung Cancer (NSCLC)
Teresa Del Giudice, Nicoletta Staropoli, Pierfrancesco Tassone, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1806-1806
Open Access | Times Cited: 5
Artificial Intelligence-Based Target for Personalized Interventions of Atherosclerosis from Gut Microbiota Signature
Suravi Majumder, Koushik Sen, Rabimba Karanjai
SynBio (2025) Vol. 3, Iss. 1, pp. 2-2
Open Access
Interplay between gut microbial communities and metabolites modulates pan-cancer immunotherapy responses
Xiaoqiang Zhu, Muni Hu, Xiaowen Huang, et al.
Cell Metabolism (2025)
Closed Access
Using mathematical modelling and AI to improve delivery and efficacy of therapies in cancer
Constantinos Harkos, Andreas G. Hadjigeorgiou, Chrysovalantis Voutouri, et al.
Nature reviews. Cancer (2025)
Closed Access
Operationalizing Team Science at the Academic Cancer Center Network to Unveil the Structure and Function of the Gut Microbiome
Kevin McDonnell
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 2040-2040
Open Access
Amelanotic Melanoma: Diagnostic Challenges, Treatment Innovations, and the Emerging Role of AI in Early Detection
Diala Ra’Ed Kamal Kakish, Jehad Feras AlSamhori, Ahmad Ayman, et al.
Journal of Medicine Surgery and Public Health (2025), pp. 100189-100189
Open Access
Optimizing anti-PD-1/PD-L1 therapy efficacy and fecal microbiota transplantation donor selection through gut mycobiome-based enterotype
Muni Hu, Xiaoqiang Zhu, Xiaowen Huang, et al.
Cell Reports (2025) Vol. 44, Iss. 5, pp. 115589-115589
Closed Access
Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients
Anna Grenda, Ewelina Iwan, Paweł Krawczyk, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6250-6250
Open Access | Times Cited: 16
Gut Microbiota a Novel Source of Biomarkers for Immunotherapy in Non-small Cell Lung Cancer (NSCLC)
Teresa Del Giudice, Nicoletta Staropoli, Pierfrancesco Tassone, et al.
(2024)
Open Access | Times Cited: 2
The Species of Gut Bacteria Associated with Antitumor Immunity in Cancer Therapy
Xiaoqiang Qi, Yajun Liu, Samira Hussein, et al.
Cells (2022) Vol. 11, Iss. 22, pp. 3684-3684
Open Access | Times Cited: 9
Clinical and molecular overview of immunotherapeutic approaches for malignant skin melanoma: Past, present and future
Raphaelly Venzel, Maria Clara Paulino Campos, Larissa Pessoa de Oliveira, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 186, pp. 103988-103988
Closed Access | Times Cited: 4
Metabolites in the Dance: Deciphering Gut-Microbiota-Mediated Metabolic Reprogramming of the Breast Tumor Microenvironment
Afaf Altrawy, Maye M. Khalifa, Asmaa Abdelmaksoud, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4132-4132
Open Access | Times Cited: 1
Insights into the Relationship Between the Gut Microbiome and Immune Checkpoint Inhibitors in Solid Tumors
Sona Ciernikova, Aneta Sevcikova, Mária Novisedláková, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4271-4271
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top